District Court Rejects Plaintiff’s Bid to Extend IPR Estoppel to Institution Denials

Feb 21, 2020

Reading Time : 2 min

Specifically, Plaintiff Finjan, Inc. sued Defendant Cisco Systems, Inc. for patent infringement based on patents related to computer and network security. Those patents have survived numerous validity and patentability challenges by multiple parties in various venues. Defendant served invalidity contentions and then filed two IPR petitions challenging the patentability of the asserted claims based on a subset of the art identified in its contentions. The Patent and Trial Appeal Board (PTAB) declined to institute review. Defendant then served its expert reports challenging the validity of the patents based on references and combinations of references that it had not asserted in the IPR.

Plaintiff moved for summary judgment that the asserted claims are valid over that prior art as a matter of law. Plaintiff argued that no reasonable jury could find that the “second-string” prior art asserted in the litigation would invalidate the patents under the “clear and convincing standard” when the PTAB declined to even institute review under the lower “reasonable likelihood” standard. Plaintiff reached that conclusion by inferring that Defendant would have used its “best” prior art in the IPR petition because: (1) IPRs are expensive; (2) there are serious estoppel considerations; and (3) the standard required to invalidate claims in IPRs is lower than in district court litigations. In response, Defendant argued that Plaintiff was effectively asking the court to invent a new estoppel arising from a denied IPR petition, and that the estoppel law does not support the labeling of prior art that was not used in a non-instituted IPR as inferior.  

The court agreed that the practical implication of Plaintiff’s theory is that whenever a defendant files an IPR petition that is not instituted, the petitioner/defendant will not be able to assert any prior art challenges in a district court because the challenges are presumably based on “second-string” references that cannot meet the higher burden of proof applied in district court. Such a holding would circumvent the statutory requirement that only final written decisions trigger estoppel. According to the court, it was irrelevant that the patents had survived previous validity challenges by other parties because none of those proceedings triggered estoppel against Defendant in this litigation.

Plaintiff did not address the substance of Defendant’s invalidity theories, and instead pointed out that some of the references in Defendant’s expert reports were considered and rejected by the PTAB. But Defendant stressed that most of its invalidity theories have never been considered by the Patent Office, PTAB, or a jury, and for the combinations that were previously considered, its expert’s analysis differed from anything presented before. The court held that Plaintiff failed to establish that there was no material dispute of fact as to the validity of the patents and thus the court denied Plaintiff’s motion for summary judgment of validity.

Practice Tip:  Evidence and argument that a patent has survived prior validity and patentability challenges may be insufficient to support a motion for summary judgment of validity. When seeking summary judgment of no invalidity, a patent owner should also consider addressing the merits of the accused infringer’s invalidity theories and identify why those theories fail as a matter of law.

Finjan, Inc. v. Cisco Sys. Inc., No. 17-cv-00072-BLF (N.D. Cal. Feb. 3, 2020) (J. B. L. Freeman)

Share This Insight

Previous Entries

IP Newsflash

October 1, 2025

In a recent final written decision, the PTAB determined that a reference patent was not prior art, despite the petitioner’s post‑filing attempt to correct its petition. While the petitioner argued that it intended to rely on the patent application’s earlier date of publication, both the corrected petition and the expert declaration continued to reference the issued patent rather than the published application.

...

Read More

IP Newsflash

September 30, 2025

The USPTO Director recently granted a petitioner’s request for rehearing of the decision discretionarily denying institution of inter partes review, ultimately vacating the original decision, and referring the petition to the board for an institution decision.

...

Read More

IP Newsflash

September 25, 2025

In considering claims to a method of reducing cardiovascular events, the Federal Circuit held that the term a “clinically proven effective” amount did not render the claims patentable over the prior art. Specifically, the Federal Circuit held that the “clinically proven effective” amount, whether limiting or not, could not be used to distinguish the prior art because the claims also specified the exact amount of the drugs to be administered in the method. The Federal Circuit also rejected patentee’s evidence of unexpected results because that evidence was tied solely to the “clinically proven effective” limitation.

...

Read More

IP Newsflash

September 24, 2025

The Federal Circuit reversed a district court’s denial of judgment as a matter of law on non-infringement, thereby setting aside a $106 million jury verdict, after holding that prosecution history estoppel barred the patentee from asserting infringement under the doctrine of equivalents.

...

Read More

IP Newsflash

September 17, 2025

A magistrate judge in the District of Delaware issued a Report and Recommendation, that found the sole asserted claim was a “single means” claim and therefore invalid for lack of enablement. In reaching that conclusion, the magistrate judge rejected the patentee’s argument that the preamble of the claim disclosed a second element that satisfied the combination requirement of Section 112, paragraph 6 because the preamble simply recited a descriptor of the very apparatus that was the subject of the means-plus-function limitation in the body of the claim. The district court judge presiding over this case has scheduled a hearing to review the magistrate’s ruling.

...

Read More

IP Newsflash

September 9, 2025

The Federal Circuit has affirmed the PTAB’s determination that a patent challenger did not show the challenged claims were unpatentable for obviousness. The Federal Circuit concluded that substantial evidence, which included expert testimony, showed there was no motivation to combine the references.

...

Read More

IP Newsflash

August 29, 2025

In a recent order addressing four IPR proceedings, the PTAB exercised its inherent authority under 37 C.F.R. § 42.5(a) to sua sponte authorize post-hearing discovery on a potentially dispositive privity issue. The order followed a Director review decision that vacated and remanded earlier IPRs involving the same parties, patent family, and privity issue. 

...

Read More

IP Newsflash

August 29, 2025

The Patent Trial and Appeal Board denied institution of an inter partes review petition in part because it determined that a patent reference was not prior art under the common ownership exception of pre-AIA 35 U.S.C. § 103(c)(1).

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.